VYKAT XR (DIAZOXIDE CHOLINE)
VYKAT XR (DIAZOXIDE CHOLINE) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: VYKAT XR; Generic name: DIAZOXIDE CHOLINE; Manufacturer: Soleno Therapeutics, Inc..
| Brand name | VYKAT XR |
|---|---|
| Generic name | DIAZOXIDE CHOLINE |
| Manufacturer | Soleno Therapeutics, Inc. |
| Used for | 1 INDICATIONS AND USAGE VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Prior to initiation, test fasting plasma glucose and HbA1c; optimize blood glucose in patients who have hyperglycemia. ( 2.1 ) Do not substitute with diazoxide oral suspension. ( 2.1 ) Administer orally once daily. ( 2.2 ) Recommended starting dosage and titration schedule is based on patient’s body weight. ( 2.2 ) Weight Starting Dosage Titration Dosage Titration Dosage Target Maintenance Dose Weeks 1 and 2 Weeks 3 and 4 Weeks 5 and 6 20 to <30 kg 25 mg 50 mg 75 mg 1 |
| Active ingredient(s) | DIAZOXIDE CHOLINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0e745e85-9512-e360-e063-6394a90aebf1 |